首页> 外文期刊>Journal of Neuropathology and Experimental Neurology: Official Journal of the American Association of Neuropathologists, Inc >Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase.
【24h】

Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase.

机译:帕金森病星形胶质细胞中蛋白酶激活受体1的上调:通过增加谷胱甘肽过氧化物酶水平,星形胶质细胞介导的神经保护作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

ABSTRACT: In the present study, we investigated the expression of protease-activated receptors (PARs), receptors for thrombin, in substantia nigra pars compacta (SNpc) of Parkinson disease (PD) brains and cultures of human neurons, astrocytes, oligodendrocytes, and microglia as determined by immunocytochemistry and reverse transcriptase-polymerase chain reaction (RT-PCR). Expression of PAR-1 was demonstrated only in glial fibrillary acidic protein-positive astrocytes in SNpc, and the number of astrocytes expressing PAR-1 increased in SNpc of PD as compared with nonneurologic control brain. Immunoreactivity for thrombin and prothrombin was stronger in astrocytes and the vessel walls in SNpc of PD brains. PAR-1 was expressed in human astrocytes and neurons, but not in oligodendrocytes or microglia as determined by RT-PCR. We investigated thrombin-mediated activation of human astrocytes. Thrombin treatment activates human astrocytes and induces morphologic change and a marked increase in proliferation of astrocytes. Increased expression of glial cell line-derived growth factor and glutathione peroxidase (GPx) but no change in the expression of nerve growth factor and inflammatory cytokines/chemokine (IL-1beta, IL-6, IL-8, MCP-1) was found in thrombin/PAR-activated astrocytes. Next, we studied the neuroprotective effect exerted by thrombin-activated astrocytes in human cerebral neuron x human neuroblastoma hybrid neurons. Although thrombin showed neurotoxicity against human hybrid neurons in a dose-dependent manner, the conditioned media derived from thrombin-pretreated astrocyte cultures promoted the survival of human hybrid neurons. The protective effect was completely inhibited with a GPx inhibitor, mercaptosuccinic acid, indicating that GPx released from thrombin/PAR-activated astrocytes is responsible for neuroprotection of hybrid neurons against thrombin cytotoxicity. The present study suggests that the increased expression of PAR-1 in astrocytes in SNpc of PD brain is the restorative move taken by the brain to provide neuroprotection against neuronal degeneration and cell death of dopaminergic neurons caused by noxious insults during the progression of PD pathology.
机译:摘要:在本研究中,我们研究了帕金森病(PD)大脑的黑质致密部(SNpc)和人类神经元,星形胶质细胞,少突胶质细胞和神经胶质细胞培养物中蛋白酶激活受体(PARs),凝血酶受体的表达。通过免疫细胞化学和逆转录聚合酶链反应(RT-PCR)确定的小胶质细胞。仅在SNpc的神经胶质纤维酸性蛋白阳性星形胶质细胞中证实了PAR-1的表达,与非神经系统对照脑相比,PD的SNpc中表达PAR-1的星形胶质细胞的数量增加了。在PD脑的SNpc中,星形胶质细胞和血管壁对凝血酶和凝血酶原的免疫反应性较强。通过RT-PCR测定,PAR-1在人星形胶质细胞和神经元中表达,但在少突胶质细胞或小胶质细胞中不表达。我们调查了凝血酶介导的人类星形胶质细胞的激活。凝血酶治疗激活人星形胶质细胞并诱导形态变化和星形胶质细胞增殖的明显增加。发现胶质细胞源性生长因子和谷胱甘肽过氧化物酶(GPx)表达增加,但神经生长因子和炎性细胞因子/趋化因子(IL-1beta,IL-6,IL-8,MCP-1)的表达未见变化在凝血酶/ PAR激活的星形胶质细胞中。接下来,我们研究了凝血酶激活的星形胶质细胞在人脑神经元x人神经母细胞瘤杂交神经元中发挥的神经保护作用。尽管凝血酶以剂量依赖的方式显示出对人类杂交神经元的神经毒性,但衍生自凝血酶预处理的星形胶质细胞培养的条件培养基促进了人类杂交神经元的存活。 GPx抑制剂巯基琥珀酸完全抑制了保护作用,表明从凝血酶/ PAR激活的星形胶质细胞释放的GPx负责杂交神经元对凝血酶细胞毒性的神经保护。本研究表明,PD脑的SNpc中星形胶质细胞中PAR-1表达的增加是大脑采取的恢复性举动,以提供针对PD病理过程中有害性损伤引起的多巴胺能神经元神经元变性和细胞死亡的神经保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号